The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 353.60
Bid: 354.80
Ask: 355.40
Change: 5.60 (1.61%)
Spread: 0.60 (0.169%)
Open: 350.20
High: 356.60
Low: 348.80
Prev. Close: 348.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of the acquisition of Avantus

23 Nov 2022 12:16

RNS Number : 3838H
QinetiQ Group plc
23 November 2022
 

News release

QinetiQ Group Plc

Completion of the acquisition of Avantus Federal LLC

23 November 2022 - QinetiQ Group plc ("QinetiQ" or the "Company") is pleased to announce that, further to the announcement on 5 August 2022, it has completed the acquisition of Avantus Federal LLC, a leading provider of cyber, data analytics and software development solutions to the US Department of Defense, Intelligence Community, Department of Homeland Security and other Federal civilian agencies.

 

The acquisition of Avantus is a major step towards achieving our strategic growth ambition in the largest defence and security market in the world. Avantus' customer relationships, contract vehicles and technical capabilities are complementary to our existing US business and the combination creates a strong platform to drive further growth in the US and beyond. Avantus is a highly attractive business at the heart of the US customers' mission and a strong strategic fit directly aligned with the Group's six distinctive offerings. We are on-track to deliver our long-term strategy to build a world-leading defence and intelligence company delivering mission-led, disruptive innovation to our customers across the US, UK, Australia and other customers around the world.

 

Since the initial announcement of the acquisition, Avantus has continued to perform well: the business has won significant new awards, maintained its high employee retention rate and delivered financial results in line with our expectations. Our integration plan has been fully prepared and we are now focused on executing the integration of Avantus to create opportunities for our customers and employees whilst delivering attractive financial returns.

 

Steve Wadey, Group Chief Executive Officer of QinetiQ, said:

 

"I am delighted that we have completed the acquisition of Avantus today - it is a strategic milestone in our five-year ambition to build an integrated global defence and security company, delivering innovation for our customers' mission. This acquisition extends our customer base, strengthens our capabilities and builds scale in the largest defence and security market in the world. With a strong track record of 10%+ growth at attractive margins, Avantus is a brilliant strategic and cultural fit and positions us to meet the increasing mission-critical needs of our US defence and intelligence customers with agility and pace."

 

Shawn Purvis, President and Chief Executive Officer of QinetiQ US, said:

 

"We are thrilled to welcome our Avantus colleagues to QinetiQ US. Avantus' elite talent, differentiated technology solutions, and dedication to mission, complement our innovative culture. I am honored to lead a combined team that shares a focus on performance and a proven ability to be agile in impactful delivery at the speed of our customers' missions"

 

Impact of acquisition on FY23 outlook

$590m paid, financed through cash and term loans; interest rate and FX were hedged at the point of announcement.

Leverage at completion is 1.1x Net Debt to EBITDA on a full year pro-forma basis - this is lower than 1.3x previously guided due to good underlying cash performance and continued discipline on working capital management. As previously communicated, we are actively planning to rapidly deleverage to less than 1x before the end of the first full year after completion.

Avantus continues to trade in line with expectations: contribution to FY23 results is expected to be c.$110m revenue with stable operating profit margins, consistent with the 10.8% operating profit margin previously guided. Longer term, we expect Avantus to deliver at least double-digit revenue growth and margins consistent with Group guidance.

With higher profit in the US, this increases our Effective Tax Rate (ETR). Our FY23 ETR will be c.13% with the partial-year contribution from Avantus. For FY24 ETR will increase to c.17% and will modestly increase thereafter. We will utilise the $70m tax asset acquired with Avantus, therefore expect zero cash tax payable in the US in the short-term, as previously guided.

 

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations: +44 (0) 7920 545841

Lorna Cobbett, Citigate Dewe Rogerson (Media enquiries): +44 (0) 7771 344781

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQPPGAGGUPPGPW
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:01 amRNSDirectorate Change, Leadership Team appointments
16th Apr 20247:00 amRNSQinetiQ Group plc Fourth Quarter Trading Update
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20244:35 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.